Medscape November 4, 2024
Carolyn Crist

PHILADELPHIA — Artificial intelligence–assisted colonoscopy (AIAC) with computer-aided detection (CADe) technology may improve adenoma detection rate (ADR), but it’s also associated with higher detection and removal of non-neoplastic lesions, according to a study presented at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting.

In particular, AIAC led to a statistically and clinically significant increase in the proportion of exams that detected lesions that after resection were all found to be benign, compared with unassisted colonoscopy.

“The potential implications include increased procedural risks, as well as costs, such as pathology costs and other healthcare expenditures, without any additional colorectal cancer prevention benefit,” said lead author Tessa Herman, MD, chief resident of internal medicine at the University of Minnesota and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Technology
Getting started with AI agents (part 1): Capturing processes, roles and connections
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
5 questions for the Abundance Institute's Neil Chilson
AI agents are unlike any technology ever
Amazon Increases Total Investment in AI Startup Anthropic to $8 Billion

Share This Article